What is AccessHope?
AccessHope is a healthcare services organization dedicated to enhancing cancer care through expert guidance and collaborative efforts. Founded in 2019 and based in Duarte, California, the company facilitates connections between employees diagnosed with cancer and their treating oncologists, linking them with subspecialists from National Cancer Institute-designated comprehensive cancer centers. This model provides access to advanced insights without necessitating patient relocation or changes in their primary care providers. AccessHope operates as a mission-driven entity, fostering partnerships with leading medical institutions such as City of Hope, Dana-Farber Cancer Institute, Johns Hopkins Medicine, and Northwestern Medicine.
How much funding has AccessHope raised?
AccessHope has raised a total of $33M across 1 funding round:
Series B
$33M
Series B (2024): $33M with participation from City of Hope
Key Investors in AccessHope
City of Hope
City of Hope is a leading U.S. cancer research and treatment organization, operating a National Cancer Institute-designated comprehensive cancer center. Its involvement suggests a strategic alignment with AccessHope's mission to advance cancer care through expert networks.
What's next for AccessHope?
The recent major strategic investment signals AccessHope's progression into a significant enterprise-level funding stage. This capital infusion is expected to fuel further expansion of its network of expert oncologists and comprehensive cancer centers, enhancing its capacity to deliver specialized cancer care guidance. The company's focus on leveraging partnerships with top-tier medical institutions positions it for continued growth and impact in the oncology support sector, aiming to improve patient outcomes through accessible, high-level expertise.
See full AccessHope company page
